Ultragenyx (RARE) Reports FDA Removal of Clinical Hold on Study Posted byZacks Equity Research September 28, 2021 Leave a comment on Ultragenyx (RARE) Reports FDA Removal of Clinical Hold on Study Ultragenyx (RARE) and GeneTx Biotherapeutics to start dosing in the phase I/II study on GTX-102 for treating pediatric patients with Angelman syndrome…